drugset / Trial / NCT02120339

Carvedilol PAH A Pilot Study of Efficacy and Safety

NCT02120339

Phase 1 Terminated 5 enrolled University of Minnesota
NaSingle-groupOpen-labelBasic science

Summary

Estimate the effect of chronic beta-adrenergic receptor blockade with carvedilol on RV function in patients with PAH. Assess the safety and tolerability of chronic carvedilol therapy in patients with PAH

Timeline

Start
2014-05
Primary completion
2015-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 6.25 mg